Inscripta, Inc.
0 followers
Inscripta is developing the world’s first benchtop platform for scalable digital genome engineering. The company’s advanced CRISPR-based platform, consisting of an instrument, consumables, software, and assays, offers a fully automated workflow that enables massively parallel, trackable editing of s... Read more
Org chart
Sri Kosaraju
Chief Executive Officer
Sri Kosaraju
Collapse
Ted Tarasow
Chief Technology Officer
Ron McGrath
Chief Financial Officer
Richard Fox
Scientific Advisory Board
Andrew Skulan
Senior Director Of Business Development & Head Of Alliances
Hanson Oshiobughie
Director of IT, Services, infrastructure and Operations
Caroline Bone, MS
Director of Business Operations
Similar companies
Code.org
10 followers
Kymera Therapeutics
5 followers
Tectonic Therapeutic
4 followers
Arbutus Biopharma
2 followers
Century Therapeutics
1 follower
ReCode Therapeutics
1 follower
Terray Therapeutics
1 follower
Newlight Technologies
1 follower
Lineage Cell Therapeutics
1 follower
T
The Institutes Knowledge Group
2 followers
Nucleate
3 followers
Discover companies